Network origin in Michael Bachner first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 24 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Bachner via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chairman | |
BVF Partners LP
 BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts. | Investment Managers | Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Chief Executive Officer Director/Board Member | |
| ACINO HOLDING AG | Pharmaceuticals: Major | Director/Board Member | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| AFFYMAX, INC. | Biotechnology | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| Karolinska Institutet | College/University | Doctorate Degree | |
| ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
| Georgetown University | College/University | Undergraduate Degree | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Director/Board Member | |
Schwartz Pharma AG
 Schwartz Pharma AG Pharmaceuticals: MajorHealth Technology Schwartz Pharma AG is a German company. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CYCLACEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Gothenburg | College/University | Doctorate Degree | |
| DIUL GROUP | Pharmaceuticals: Major | Chairman | |
HeiQ Materials AG
 HeiQ Materials AG TextilesProcess Industries HeiQ Materials AG develops and manufactures antimicrobial silver and other sustainable textile effects. It offers textile brands innovation research and development, customized chemical manufacturing, and ingredient branding in one. The company was founded by Carlo Centonze and Murray Height in 2005 and is headquartered in Schlieren, Switzerland. | Textiles | Director/Board Member | |
Pfizer Japan, Inc.
 Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy. | Miscellaneous Commercial Services | Director/Board Member | |
| Pharmacia GmbH | Private Equity Investor | ||
| Janssen Alzheimer Immunotherapy | Corporate Officer/Principal General Counsel | ||
| Serono International SA | Corporate Officer/Principal | ||
EcoR1 Capital, LLC
 EcoR1 Capital, LLC Investment ManagersFinance EcoR1 Capital LLC (EcoR1) is an independent registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Oleg Nodelman in 2012. EcoR1 serves as the general partner of and investment adviser to investment funds and provides investment advice to separate account clients. | Investment Managers | Chief Executive Officer | |
Prothena Biosciences, Inc.
 Prothena Biosciences, Inc. BiotechnologyHealth Technology Part of Prothena Corp. Plc, Prothena Biosciences, Inc. is a company that specializes in the biology of misfolded proteins. The company is based in South San Francisco, CA. The company has over 3 decades of expertise in this field and offer a range of services including science, pipeline, clinical trial information, and more. | Biotechnology | Director/Board Member Chairman | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Chairman | |
| CODEMILL AB | Packaged Software | Comptroller/Controller/Auditor | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AFYX Therapeutics AS
 AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Miscellaneous Commercial Services | Chairman | |
| EcoR1 Panacea Holdings LLC | Chief Executive Officer | ||
| NUVATION BIO INC. | Biotechnology | Chairman Director/Board Member | |
| PANACEA ACQUISITION CORP. II | Financial Conglomerates | Chief Executive Officer | |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
ADAMA Agriculture BV
 ADAMA Agriculture BV Chemicals: AgriculturalProcess Industries ADAMA Agriculture BV is a Dutch company that manufactures biocidal products for crop protection. The private company is based in Leusden, NL. and has subsidiaries in Italy, Romania, Czechia and United Kingdom. | Chemicals: Agricultural | Chief Executive Officer | |
| ALKERMES PLC | Pharmaceuticals: Major | Director/Board Member Public Communications Contact | |
| BRAIN+ A/S | Packaged Software | Chairman |
Statistics
International
| United States | 29 |
| Switzerland | 6 |
| Sweden | 6 |
| Ireland | 4 |
| Germany | 3 |
Sectoral
| Health Technology | 31 |
| Finance | 6 |
| Consumer Services | 4 |
| Process Industries | 3 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 97 |
| Corporate Officer/Principal | 62 |
| Independent Dir/Board Member | 40 |
| Chairman | 34 |
| Undergraduate Degree | 19 |
Most connected contacts
| Insiders | |
|---|---|
| Helen Kim | 34 |
| Daniel Welch | 24 |
| Karl Härfstrand | 23 |
| Lars Ekman | 21 |
| Christopher Henney | 18 |
| Dennis Selkoe | 16 |
| Oleg Nodelman | 15 |
| Shane Cooke | 13 |
| Tran Nguyen | 10 |
| Sanjiv Patel | 9 |
| Hideki Garren | 9 |
| Michael J. Malecek | 8 |
| Paula Cobb | 8 |
| Richard Collier | 8 |
| Carol Karp | 8 |
- Stock Market
- Insiders
- Michael Bachner
- Company connections
